Christopher Zahn
Dr. Christopher Zahn is the chief of clinical practice for the American College of Obstetricians and Gynecologists, where he emphasizes the importance of judicious use of acetaminophen during pregnancy, advocating for patient safety while addressing the complexities surrounding neurodevelopmental disorders.
Not in the pool (under ¢1).
Recent news mentions
Christopher Zahn emphasized that acetaminophen is safe for pregnant women.
Trump vincula el paracetamol con el autismo, pese a que no hay evidencia científica | Sociedad
Spain· 2025-09-23
Dr. Christopher Zahn stated that there is no clear evidence linking acetaminophen use during pregnancy to fetal developmental issues.
Autism: Trump previews ‘amazing’ announcement Monday
United States· 2025-09-22
Dr. Christopher Zahn emphasized that neurodevelopmental disorders are multifactorial and difficult to associate with a singular cause.
In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reportsUnited States· 2025-09-12
Christopher Zahn, chief of clinical practice for the American College of Obstetricians and Gynecologists, stated there is no clear evidence that proves a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues.
Kennedy Jr. plans to link Tylenol use in pregnancy to autism, report says
Canada· 2025-09-06
Christopher Zahn is the chief of clinical practice at the American College of Obstetricians and Gynecologists who stated there is no clear evidence linking acetaminophen use during pregnancy to fetal developmental issues.
Tylenol-maker shares hit after report RFK Jr will suggest autism link
United Kingdom· 2025-09-06
Dr. Christopher Zahn, chief of clinical practice for the American College of Obstetricians and Gynecologists, stated that there is no clear evidence linking acetaminophen use during pregnancy to fetal developmental issues.
Upcoming HHS report will link autism to common pain reliever, folate deficiency in pregnancy, Wall Street Journal reportsUnited States· 2025-09-05